The purpose of this study is to compare the tolerability of the application of a combination of a serum containing human bone marrow stem cell derived growth factor (SCR Complex) and cytokines and a botanical lipid-based occlusive (Bio Cel) immediately following fractional radiofrequency treatment using the Venus Viva versus standard of care.
Age range
21 Years – 75 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Subject Treatment Tolerability Score Post Treatment 1 at 24hrs Post Treatment
Timeframe: 24hr post treatment one
Subject Treatment Tolerability Score Post Treatment 1 at 72hrs Post Treatment
Timeframe: 72 hrs post treatment one
Subject Treatment Tolerability Score Post Treatment 2 at 24hrs Post Treatment
Timeframe: 24hr post treatment two
Subject Treatment Tolerability Score Post Treatment 2 at 72 Hrs Post Treatment
Timeframe: 72hr post treatment two